Hayden is an assistant editor for The American Journal of Managed Care® (AJMC®) and joined AJMC® in 2021, where she produces written and video content covering multiple disease states.
She has a BA in journalism & media studies from Rutgers University. You can connect with Hayden on LinkedIn.
TDF-Based PrEP Associated With Increased Risk of Kidney Adverse Events, Review Finds
April 27th 2022According to a review, few individuals initiating tenofovir disoproxil fumarate (TDF)–based HIV pre-exposure prophylaxis (PrEP) experienced clinically significant kidney impairment, although the risk was increased.
Read More
Dr Elaine Goodman: Why Health Care Systems Should Consider the Patient Perspective
April 26th 2022When clinicians consider the patient journey from beginning to end, they begin to understand how difficult it is for patients to access care, said Elaine Goodman, MD, MBA, clinical lead for population health management, Mass General Brigham.
Read More
High Prevalence of Metabolic Syndrome in Patients With RA Warrants Early Identification Measures
April 26th 2022A meta-analysis found that a third of patients with rheumatoid arthritis (RA) in a sample had metabolic syndrome, which can double the risk of cardiovascular outcomes in this population.
Read More
Dr Hatem Soliman Addresses the Economic Burden of Metastatic Breast Cancer Treatment
April 25th 2022The financial toxicity of newer metastatic breast cancer (MBC) treatments is a significant concern and requires stakeholders to work together to find the best value- and evidence-based treatments for patients, said Hatem Soliman, MD, medical director, Clinical Trials Office, Moffitt Cancer Center.
Read More
Secukinumab 300 mg Dose Improved Symptoms of Psoriatic Arthritis, Study Finds
April 23rd 2022Results from the CHOICE study suggest that both a 150 mg and 300 mg dose of secukinumab improved symptoms of psoriatic arthritis (PsA) in biologic-naïve patients, with higher response rates for the 300 mg dose.
Read More
Dr Hatem Soliman on Disparities in Metastatic Breast Cancer
April 21st 2022A combination of biology, access issues, and delayed diagnoses have contributed to disparities experienced by Black women with metastatic breast cancer, explained Hatem Soliman, MD, medical director of the Clinical Trials Office, Moffitt Cancer Center.
Read More
Dr Dexter Shurney Explains Role of Health Care Systems in Promoting Food as Medicine
April 21st 2022Dexter Shurney, MD, MBA, MPH, chief health equity, diversity, and inclusion officer and chief medical officer at Adventist Health, explains the roles of health care systems and managed care organizations, and next steps to update policies, to ensure healthy food is available in all areas of the United States.
Read More
Dr Dexter Shurney Previews NAMCP, Conversation on Food as Medicine
April 18th 2022Dexter Shurney, MD, MBA, MPH, chief health equity, diversity, and inclusion officer and chief medical officer at Adventist Health, discusses the concept of "food as medicine," which he will be explaining further at the National Association of Managed Care Physicians (NAMCP) Spring Managed Care Forum.
Read More
Dr Stephen Schleicher Previews Nashville IVBM Meeting
April 18th 2022Stephen M. Schleicher, MD, MBA, chief medical officer, Tennessee Oncology, previews the Nashville meeting of The American Journal of Managed Care®'s Institute for Value-Based Medicine® (IVBM), co-hosted by Tennessee Oncology.
Read More
Study Finds No Association Between Targeted DMARDs, ADRD Risk Among Patients With RA
April 12th 2022Researchers found no association between the use of tofacitinib, tocilizumab, or tumor necrosis factor (TNF) inhibitors and risk of developing Alzheimer disease and related dementia (ADRD) among older patients with rheumatoid arthritis (RA).
Read More
Dr Bernice Kwong Discusses Impact of Delayed Diagnosis, Treatment for GVHD
April 8th 2022Bernice Kwong, MD, clinical professor of dermatology, Stanford University, talks about how later diagnosis and treatment for graft-versus-host disease (GVHD) affects disease progression and overall patient outcomes.
Read More
Protease Inhibitor–Based ART Associated With Babies Born Small or Very Small
April 6th 2022A large systematic review on pregnant women living with HIV found that protease inhibitor–based antiretroviral therapy (ART) use was associated with increased risk of babies being born small or very small for their gestational age, but not with other adverse pregnancy outcomes.
Read More
Dr Dennis Scanlon on Barriers for Learning Health Care Systems
April 6th 2022Dennis P. Scanlon, PhD, professor of health policy and administration at Pennsylvania State University and editor-in-chief of The American Journal of Accountable Care®, talks about major systemic and fundamental barriers to health systems becoming learning health systems.
Read More
NFID Board Members Discuss Solutions to RSV-Related Disparities
April 2nd 2022William Schaffner, MD, medical director at the National Foundation for Infectious Diseases (NFID), and Patsy Stinchfield, RN, MS, CPNP, president-elect of NFID, discuss health care disparities related to respiratory syncytial virus (RSV), as well as solutions to close these gaps.
Read More